Disease/specialty area | Number of FP7 product-related awards | Total EC funding across awards |
---|---|---|
Neonatal/paediatric | 27 | € 144,697,453.51 |
Infection | 22 | € 103,803,065.19 |
Cancer | 19 | € 98,467,149.13 |
Cardiovacular | 7 | € 53,059,136.35 |
Diabetes | 7 | € 39,387,415.80 |
Neurology | 5 | € 39,361,768.70 |
Rheumatology | 5 | € 38,211,526.50 |
Neurodegenerative | 4 | € 26,594,086.00 |
Immunology | 4 | € 25,825,968.00 |
Genetic diseases | 4 | € 22,702,610.55 |
Eye/ear | 4 | € 20,227,976.98 |
Respiratory | 3 | € 17,974,237.00 |
Orthopaedics | 2 | € 17,649,160,30 |
Regenerative medicine | 1 | € 11,935,340.00 |
Psychiatry | 1 | € 5,994,380.00 |
Skin | 1 | € 4,961,654,00 |
Gastroenterology | 1 | € 4,951,792.40 |
Brain | 1 | € 4,865,656,00 |
Endocrinology | 1 | € 3,308,154.00 |
Urology | 1 | € 2,892,869.00 |
Total | 120 | € 686,871,399.41 |